Ensure Drug Safety & Efficacy with Expert Immunogenicity Testing

Pharmaron provides industry-leading immunogenicity services to assess anti-drug antibodies (ADA), neutralizing antibodies (NAb), and cellular immune responses. Our multi-tiered approach, aligned with FDA guidelines, ensures high-quality data to support biologics, biosimilars, and gene therapy programs.

With expertise in ligand binding assays, ELISA, flow cytometry, and PBMC-based immune response testing, we deliver reliable, regulatory-compliant immunogenicity assessments for preclinical and clinical development.

Key Immunogenicity Testing Capabilities:

• Humoral Immune Response – ADA detection, titration, and neutralizing antibody assays
• Cellular Immune Response – PBMC assays for cytokine profiling and antigen-specific T-cell analysis
• Multi-Tiered Immunogenicity Testing – Screening, confirmatory assays, and NAb titer evaluation
• Regulatory-Compliant Study Design – Supporting FDA, EMA, and ICH immunogenicity guidelines
• State-of-the-art technology Platforms – ELISA, MSD, Luminex, and flow cytometry

Our comprehensive immunogenicity services provide critical insights into drug safety, pharmacokinetics, and efficacy, helping biotech and pharmaceutical companies navigate regulatory expectations and mitigate risks.

Why Choose Pharmaron for Immunogenicity Testing?

• Experienced Leader in Biologics & Gene Therapy Immunogenicity
• Advanced ADA, NAb, and Cellular Response Assays
• Regulatory-Ready Data to Support Drug Development & Approval

Optimize your AAV vector manufacturing early. Download our service overview to explore our small-scale AAV solutions.